Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Surgical Innovations ( (GB:SUN) ) has shared an announcement.
Surgical Innovations Group, a UK-based medical technology company, specialises in designing, manufacturing and distributing devices for minimally invasive surgery, including branded port access systems, surgical instruments and retraction devices. Its Elemental Healthcare subsidiary handles direct UK sales and exclusive distribution of certain specialist surgical products, while a network of international partners supports exports, and the Group also develops devices for OEM clients and industrial engineering projects.
The company announced it will publish its final results for the year ended 31 December 2025 on 21 April 2026 and will host a live investor presentation the same day via the Investor Meet Company platform. The briefing, led by the CEO and CFO, is open to existing and potential shareholders, underscoring efforts to maintain active investor engagement and provide transparency around financial performance and strategic progress.
The most recent analyst rating on (GB:SUN) stock is a Hold with a £0.44 price target. To see the full list of analyst forecasts on Surgical Innovations stock, see the GB:SUN Stock Forecast page.
Spark’s Take on SUN Stock
According to Spark, TipRanks’ AI Analyst, SUN is a Neutral.
The overall stock score of 43 reflects significant financial challenges, including declining revenue and negative profitability, which are the most impactful factors. Technical analysis indicates a bearish trend, further weighing on the score. Valuation is also a concern due to the negative P/E ratio and lack of dividend yield.
To see Spark’s full report on SUN stock, click here.
More about Surgical Innovations
Surgical Innovations Group is a UK-based designer, manufacturer and distributor of innovative medical technology focused on minimally invasive surgery. Through its own brands and its Elemental Healthcare subsidiary, the Group supplies port access systems, surgical instruments and retraction devices, as well as specialist products for laparoscopy, bariatric and metabolic surgery, hernia repair and breast reconstruction.
Its portfolio combines reusable and disposable elements in a “resposable” model aimed at reducing plastic waste and CO2 emissions while remaining cost competitive with fully disposable products. The company also develops devices for OEM partners and provides precision engineering solutions beyond the medical sector, distributing its products in the UK and globally via a network of partners.
Average Trading Volume: 305,709
Technical Sentiment Signal: Strong Sell
Current Market Cap: £4.2M
See more insights into SUN stock on TipRanks’ Stock Analysis page.